Join us for a state-of-the-art update in benign #hematology, covering complex hemostasis & thrombosis management, advances in hemolytic anemias, hematologic complications of cellular & immunotherapies, and emerging treatment strategies. Learn more: bit.ly/Thrombosis2025 @hemejz.bsky.social

Stand up for science!

Trump & Musk are making massive cuts to the National Institutes of Health. I know there is a lot going on right now, but this is one of worst things they have done so far, will affect cancer research and trials, the search for cures, innovation and competitiveness, our universities. Your lives.

Tacos at Los Chuchys is a 5 min walk. Fantastic!

Looking forward to a great Friday Scientific Workshop on Coagulation and Malignancy. Hope to see you there! www.hematology.org/meetings/ann...

Ivan Maillard Named Head of the Division of Hematologic Malignancies at Memorial Sloan Kettering Cancer Center www.mskcc.org/news-release...?

Ivan Maillard Named Head of the Division of Hematologic Malignancies at Memorial Sloan Kettering Cancer Center

Ivan Maillard, MD, PhD, has been named Head of the Division of Hematologic Malignancies within the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK).

mskcc.org